Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona, 37134 Verona, Italy.
Cells. 2021 Nov 12;10(11):3149. doi: 10.3390/cells10113149.
The wild-type protein p53 plays a key role in preventing the formation of neoplasms by controlling cell growth. However, in more than a half of all cancers, the gene has missense mutations that appear during tumorigenesis. In most cases, the mutated gene encodes a full-length protein with the substitution of a single amino acid, resulting in structural and functional changes and acquiring an oncogenic role. This dual role of the wild-type protein and the mutated isoforms is also evident in the regulation of the redox state of the cell, with antioxidant and prooxidant functions, respectively. In this review, we introduce a new concept of the p53 protein by discussing its sensitivity to the cellular redox state. In particular, we focus on the discussion of structural and functional changes following post-translational modifications of redox-sensitive cysteine residues, which are also responsible for interacting with zinc ions for proper structural folding. We will also discuss therapeutic opportunities using small molecules targeting cysteines capable of modifying the structure and function of the p53 mutant isoforms in view of possible anticancer therapies for patients possessing the mutation in the gene.
野生型蛋白 p53 通过控制细胞生长在预防肿瘤形成中起着关键作用。然而,在所有癌症的一半以上中,该基因在肿瘤发生过程中出现错义突变。在大多数情况下,突变基因编码一个全长蛋白,其中一个氨基酸被取代,导致结构和功能发生变化,并获得致癌作用。野生型蛋白和突变同种型的这种双重作用也在细胞氧化还原状态的调节中表现出来,分别具有抗氧化和促氧化作用。在这篇综述中,我们通过讨论其对细胞氧化还原状态的敏感性,引入了 p53 蛋白的新概念。特别是,我们专注于讨论在氧化还原敏感半胱氨酸残基的翻译后修饰之后发生的结构和功能变化,这些残基还负责与锌离子相互作用以进行适当的结构折叠。我们还将讨论使用针对半胱氨酸的小分子的治疗机会,这些半胱氨酸能够修饰 p53 突变同种型的结构和功能,以期为携带基因中突变的患者提供可能的抗癌治疗。